Continued declining incidence and improved survival of progressive multifocal leukoencephalopathy in HIV/AIDS

J L Casado1, I Corral, J García

  • 1Department of Infectious Diseases, Ramón y Cajal Hospital, 28034, Madrid, Spain, jcasado.hrc@gmail.com.

Insights

Progressive multifocal leukoencephalopathy (PML) incidence in human immunodeficiency virus (HIV)-infected patients has declined significantly. Improved survival rates are linked to higher CD4+ counts and cerebrospinal fluid (CSF) inflammation.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Immunology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, opportunistic infection affecting the central nervous system.
  • In human immunodeficiency virus (HIV)-infected individuals, PML was historically associated with severe immunosuppression and poor prognosis.
  • The advent of highly active antiretroviral therapy (HAART) has altered the epidemiology and clinical course of many opportunistic infections in HIV/acquired immunodeficiency syndrome (AIDS) patients.

Purpose of the Study:

  • To evaluate the changing incidence, causes, and long-term outcomes of PML in HIV-infected patients.
  • To analyze trends in PML diagnosis and survival across different periods of HAART availability.
  • To identify factors associated with improved survival in HIV-associated PML.

Main Methods:

  • Retrospective analysis of 72 acquired immunodeficiency syndrome (AIDS) patients diagnosed with PML between 1996 and 2011.
  • Classification of patients into three diagnostic periods: 1996-2000, 2001-2006, and 2007-2011 (HAART era).
  • Evaluation of incidence rates, CD4+ T-cell counts, cerebrospinal fluid (CSF) profiles, and survival data using statistical analyses, including Cox regression.

Main Results:

  • Overall PML incidence decreased significantly from 14.8 cases/1,000 patient-years in 1996 to 0.8 in 2011.
  • A higher proportion of recent PML cases (64%) occurred in HIV patients not attending clinical visits.
  • Patients diagnosed more recently exhibited higher median CD4+ counts, increased CSF inflammatory profiles, and significantly longer survival rates (1-year survival up to 79% for CD4+ >100 cells/mm³).

Conclusions:

  • The incidence of PML in HIV-infected patients has dramatically declined.
  • Improved long-term survival in HIV-associated PML is associated with higher baseline CD4+ counts and CSF inflammatory markers.
  • Despite declining incidence, PML remains a significant concern, particularly in patients with poor clinical engagement.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...